Pure Global

READY-TO-USE SYRINGE CONTAINING AMGEVITA 40 MG/0.8 ML SOLUTION FOR INJECTION (1 PIECE) - Turkey License c60df2416d7c88ab5019951d9dd2d13c

Access comprehensive regulatory information for READY-TO-USE SYRINGE CONTAINING AMGEVITA 40 MG/0.8 ML SOLUTION FOR INJECTION (1 PIECE) in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number c60df2416d7c88ab5019951d9dd2d13c with license number 2018/492and contains active ingredient adalimumab. The license is held by AMGEN İLAÇ TİC. LTD. ŞTİ..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
21,000+ Products
c60df2416d7c88ab5019951d9dd2d13c
License Details
Turkey SFDA License: c60df2416d7c88ab5019951d9dd2d13c
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Product Details

READY-TO-USE SYRINGE CONTAINING AMGEVITA 40 MG/0.8 ML SOLUTION FOR INJECTION (1 PIECE)
TR: AMGEVİTA 40 MG/0.8 ML ENJEKSİYONLUK ÇÖZELTİ İÇEREN KULLANIMA HAZIR ENJEKTÖR (1 ADET)
Pharmaceutical Product

License Details

c60df2416d7c88ab5019951d9dd2d13c

2018/492

8699862950206

L04AB04

License Holder Information

Active Ingredient

adalimumab

License Information

Sep 12, 2018